SAMANTHA OLENIC: Open Payments
NPI 1396502449 · BEAVER, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,022 in 73 payments from 22 companies in 2025. Trend: 2023 $0 · 2024 $1,250 · 2025 $2,022
Food & beverage: $2,022
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 12 | $438 |
| ABBVIE INC. | 11 | $410 |
| GlaxoSmithKline, LLC. | 11 | $302 |
| Phathom Pharmaceuticals, Inc. | 3 | $161 |
| Amgen Inc. | 9 | $154 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $72 |
| PFIZER INC. | 3 | $66 |
| Lilly USA, LLC | 3 | $60 |
| AstraZeneca Pharmaceuticals LP | 3 | $55 |
| Sumitomo Pharma America, Inc. | 3 | $48 |
Products named: QULIPTA, Ozempic, Wegovy, VOQUEZNA, AREXVY, TRELEGY ELLIPTA, UBRELVY, EVENITY.
Industry payments across PA — which companies pay providers there.
